Sriram Subramaniam

As the founder and CEO of Gandeeva Therapeutics Inc., I am seeking to achieve transformative societal impact on public health by revolutionizing drug discovery and by lowering risks of late-stage clinical failures. Gandeeva’s central goal is to harness the transformative power of cryo-electron microscopy and machine learning to accelerate the development of effective therapeutic agents. We are rapidly growing – join us! Over my 20+ years of experience in all aspects of structural biology and as the director of world-leading structural biology teams at the National Institutes of Health and University of British Columbia (current), I’ve led the exploration of structural biology and drug discovery using cryo-EM, as they relate to imaging molecules, viruses and cells.